// ai capability

All signals tagged with this topic

May 10

AI penetration testing slashes costs from $50K to minutes

Intruder's automated pentest tool erodes the economic moat protecting penetration testing as a high-friction, high-cost service. Historically, cost alone gatekept the work to well-funded enterprises. The shift from weeks-long manual engagements to minutes of AI-driven scanning will fragment the market: commodity vulnerability detection becomes cheaper and continuous, while human pentesters either specialize in complex social engineering and threat modeling, or face margin compression. This pattern appeared in code review and legal discovery, where AI commoditizes routine work but doesn't eliminate skilled practitioners—it forces repositioning.

theme-ai ai capability security research model applications

May 10

Anthropic's AI discovered thousands of zero-day flaws; regulators scrambled

Source: The Next Web

Anthropic's vulnerability-hunting model exposed thousands of unmapped security holes across major operating systems and browsers, prompting the Federal Reserve and financial regulators to coordinate immediately with banks. The scale exceeded industry expectations and suggests either that legacy systems are far more fragmented than institutions assumed, or that AI can now discover attack surface faster than traditional patching cycles allow—creating compliance and liability problems for regulated firms unable to patch at machine speed.

theme-ai AI & ML ai capability healthcare AI

Apr 30

Mayo Clinic AI spots pancreatic cancer 15 months early on routine scans

Source: Bloomberg

Redmod shows that AI systems trained on retrospective imaging data can deliver clinical value: a 475-day lead time on pancreatic cancer detection materially improves survivorship odds for a disease where early intervention drives outcomes. The finding is not a proof-of-concept but a validation that radiologists systematically miss actionable signals in existing scan archives. Deploying similar models across health systems could unlock diagnostic gains without new infrastructure or patient workflows. Mayo's credibility accelerates the path for pancreatic-cancer-specific AI tools to move from research papers into clinical protocols at other major systems.